🔗 Permalink

Inventor profile of:

Birgit Bossenmaier

City:

Seefeld

Country:

Germany

Published Applications:

Last publication date:

2022-05-19

Top Assignees for applications by Birgit Bossenmaier

The entities that hold a legal rights for patent applications filed by inventor Bossenmaier Birgit:

Hoffmann-La Roche Inc. 15 Nutley, NJ United States
HOFFMANN-LA ROCHE INC. 13 Little Falls, NJ United States
ROCHE GLYCART AG 9 Schlieren, Switzerland
Hoffman-La Roche Inc. 2 Little Falls, NJ United States
Hoffman-La Roche. Inc. 1 Nutley, NJ United States
Roche Molecular Systems, Inc. 1 Pleasanton, CA United States
PIERIS PHARMACEUTICALS GMBH 1 Hallbergmoos, Germany
VENTANA MEDICAL SYSTEMS, INC. 1 Tucson, AZ United States

Recent patent applications by Bossenmaier Birgit

Birgit Bossenmaier from Seefeld, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-05-19

US20220153864A1

Chemistry; metallurgy

Novel Fusion Proteins Specific for CD137 and GPC3

#2 | 2018-11-01

US20180312573A1

Chemistry; metallurgy

Nucleic acid encoding dual Fc antigen binding proteins

#3 | 2018-05-03

US20180118837A1

Chemistry; metallurgy

Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4

#4 | 2018-04-12

US20180100022A1

Chemistry; metallurgy

HER1 ANTIGEN BINDING PROTEINS BINDING TO THE BETA-HAIRPIN OF HER1

#5 | 2018-04-05

US20180094062A1

Chemistry; metallurgy

HER3 antigen binding proteins binding to the beta-hairpin of HER3

#6 | 2018-02-08

US20180037633A1

Chemistry; metallurgy

Monovalent antigen binding proteins

#7 | 2017-08-17

US20170233490A1

Chemistry; metallurgy

HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2

#8 | 2017-06-22

US20170174784A1

Chemistry; metallurgy

Anti-HER3 antibodies and uses thereof

#9 | 2017-04-06

US20170096487A1

Chemistry; metallurgy

Antibodies specifically binding to HER3

#10 | 2016-06-09

US20160159912A1

Chemistry; metallurgy

COMBINATION THERAPY OF ANTI-HER3 ANTIBODIES

#11 | 2016-01-07

US20160002346A1

Chemistry; metallurgy

HER1 antigen binding proteins binding to the beta-hairpin of HER1

#12 | 2016-01-07

US20160002338A1

Chemistry; metallurgy

Anti-HER3 antibodies binding to the beta-hairpin of HER3

#13 | 2014-12-25

US20140377273A1

Chemistry; metallurgy

Anti-HER3 antibodies and uses thereof

#14 | 2014-12-25

US20140377272A1

Chemistry; metallurgy

ANTI-HER3 ANTIBODIES AND USES THEREOF

#15 | 2014-08-14

US20140227255A1

Human necessities

Combination therapy of anti-HER3 antibodies

#16 | 2014-07-03

US20140186358A1

Chemistry; metallurgy

HER3 antibodies binding to the beta-hairpin of HER3

#17 | 2014-07-03

US20140186354A1

Chemistry; metallurgy

Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4

#18 | 2014-05-15

US20140135482A1

Chemistry; metallurgy

Bispecific Anti ErbB3 / Anti cMet Antibodies

#19 | 2013-10-17

US20130273054A1

Chemistry; metallurgy

Bispecific Anti ErbB2/Anti cMet Antibodies

#20 | 2013-08-15

US20130209455A1

Chemistry; metallurgy

Humanized anti-CDCP1 antibodies

#21 | 2013-06-20

US20130156772A1

Chemistry; metallurgy

Bispecific Anti ErbB1 / Anti cMet Antibodies

#22 | 2012-09-20

US20120237507A1

Chemistry; metallurgy

Monovalent Antigen Binding Proteins

#23 | 2012-09-20

US20120237506A1

Chemistry; metallurgy

Dual FC antigen binding proteins

#24 | 2011-07-14

US20110171222A1

Chemistry; metallurgy

Anti-HER3 antibodies and uses thereof

#25 | 2011-07-07

US20110165082A1

Human necessities

Method for determining the anti-tumor efficacy of monoclonal antibodies

#26 | 2011-05-19

US20110117096A1

Chemistry; metallurgy

Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies

#27 | 2011-03-24

US20110070246A1

Chemistry; metallurgy

Antibodies against CDCP1 for the treatment of cancer

#28 | 2011-03-03

US20110052582A1

Chemistry; metallurgy

Humanized anti-CDCP1 antibodies

#29 | 2010-10-07

US20100256339A1

Human necessities

Bispecific Anti ErbB3 / Anti cMet Antibodies

#30 | 2010-10-07

US20100254989A1

Human necessities

Bispecific Anti ErbB1 / Anti c Met Antibodies

#31 | 2010-10-07

US20100254988A1

Human necessities

Bispecific Anti ErbB2 / Anti cMet Antibodies

#32 | 2007-04-17

US10833721

Aniline derivatives, their manufacture and use as pharmaceutical agents

#33 | 2007-04-17

US10808935

Oxazole derivatives

#34 | 2007-02-08

US20070032530A1

Chemistry; metallurgy

Phenylpyridine derivatives

#35 | 2006-06-01

US20060116407A1

Chemistry; metallurgy

Amide derivatives

#36 | 2005-12-01

US20050267179A1

Chemistry; metallurgy

Thioether derivatives

#37 | 2005-12-01

US20050267178A1

Chemistry; metallurgy

Benzylether derivatives

#38 | 2005-10-06

US20050222228A1

Chemistry; metallurgy

Diazine derivatives

#39 | 2005-09-22

US20050209290A1

Chemistry; metallurgy

Ether derivatives

#40 | 2005-09-15

US20050203064A1

Chemistry; metallurgy

Oxidized thioether derivatives

#41 | 2005-09-08

US20050197370A1

Chemistry; metallurgy

Pentafluorosulfanyl compounds

#42 | 2005-06-09

US20050124670A1

Chemistry; metallurgy

Arylazole derivatives, their manufacture and use as pharmaceutical agents

#43 | 2005-02-17

US20050038091A1

Chemistry; metallurgy

Oxazoles, their manufacture and use as pharmaceutical agents

InventorID:

298681 ⎘